https://www.medigaplife.com/wp-content/uploads/2021/07/alzheimersdrug.jpg13572550adminhttps://www.medigaplife.com/wp-content/uploads/2019/11/MGL_Horizontal_logoforwebsite-1.jpgadmin2021-07-01 16:09:532021-07-01 16:10:08FDA’s Approval of Biogen’s New Alzheimer’s Drug Has Huge Cost Implications for Medicare and Beneficiaries